Refreshing results…
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study
UploadEvolving management strategies for lymphomas during the COVID-19 pandemic
UploadMissing publications? Search for publications with a matching author name.